2023

1. Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study

   Journal of Clinical Oncology, Vol. 41, Núm. 14, pp. 2651-2660